Evidence map›Paper›PMID 35986606›Full record

ArticleInternational journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics2023

Fibrinogen for the prediction of severe maternal complications in placental abruption with fetal death after 24 weeks of gestation.

Anthony Atallah, Gaelle Piccin, Gil Dubernard, Marie Jo Abdul-Hay, Marion Cortet, Cyril Huissoud

Open access · hybridAbstract read
In one paragraph

Article in International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
4.6field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 13 citations in OpenAlex.

  1. Genetic Associations ofInternational journal of molecular sciences · 2025
    Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Fibrinogen for the prediction of severe maternal complications in placental abruption with fetal death after 24 weeks of gestation.International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics · 2023
    Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Anthony AtallahFemme Mère Enfant University Hospital, Department of Maternal-Fetal Medicine and Obstetric Emergency Department, Hospices Civils de Lyon, Bron, France.ORCID https://orcid.org/0000-0002-4805-2083
Gaelle PiccinDepartment of Obstetrics and Gynecology, North-West Hospital of Villefranche-sur-Saône, Gleize, France.
Gil DubernardClaude Bernard University Lyon 1, Lyon, France.
Marie Jo Abdul-HayUniversity of Toronto-St. George Campus, Toronto, Ontario, Canada.
Marion CortetClaude Bernard University Lyon 1, Lyon, France.
Cyril HuissoudFemme Mère Enfant University Hospital, Department of Maternal-Fetal Medicine and Obstetric Emergency Department, Hospices Civils de Lyon, Bron, France.
Université Claude Bernard Lyon 1 · FRUniversity of Toronto · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo assess the correlation between standard laboratory indicators at admission and severe maternal complications due to placental abruption (PA) with intrauterine fetal death (IUFD) after 24 weeks.

methodsRetrospective study in three French tertiary referral hospitals. Correlation of laboratory indicators at admission (platelet count, prothrombin, activated partial thromboplastin time, fibrinogen) and severe maternal complications (massive transfusion, multiple organ failure, hysterectomy, or maternal deaths) in patients with PA and IUFD.

resultsOver 12 years, we identified 27/344 (7.8%) pregnant women presenting PA with IUFD. No patient had coagulopathy at admission. Fifteen individuals (55.5%) underwent delivery by cesarean section before or during labor. Fifteen individuals (55.5%) presented severe complications, and 17/27 (63%) lost more than 1 L of blood during delivery. Fibrinogen level was shown to be the laboratory indicator most correlated with severe complications (r = -0.52, P = 0.01). The receiver operating characteristic curve of fibrinogen less than 1.9 g/L in the prediction of severe complications (area under the curve = 0.80, 95% confidence interval [CI] 0.54-0.97) showed both a sensitivity and specificity of 83% (95% CI 54%-96%).

conclusionsIn cases of IUFD with PA, fibrinogen levels at admission had a prognostic value for the prediction of severe maternal complications.

Indexed as

Abruptio PlacentaeHemostaticsCesarean SectionFemaleFetal DeathFibrinogenHumansPlacentaPregnancyRetrospective StudiesStillbirthFibrinogenHemostaticsdisseminated intravascular coagulationfetal deathfibrinogenmaternal prognosisplacental abruption

Identifiers

PMID35986606
PMCPMC10087485
OpenAlexW4294215497

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.